Drug and Device Customs Rulings Summary Q1 2018
Life Sciences Trade Alert’s Drug and Device Customs Rulings Summary is now available as a FREE resource for trade compliance professionals in the healthcare sector! Get all of CBP’s prospective rulings affect the pharmaceutical, medical device and biotechnology sectors in one convenient report. This two-part summary includes coverage of the first quarter of 2018, as well as a list of rulings issued by CBP’s National Commodity Specialist Division detailing the products subjected to ruling requests and CBP’s decision on their tariff classification.
Part One outlines rulings made by CBP Headquarters regarding classifications, declarations and country of origin. Ruling summaries that affect healthcare include drugs in clinical trials, prices paid by manufacturers and middlemen and more.
Part Two includes a list of CBP New York Ruling Summaries addressing:
- Hormonal Implants
- Prebiotic Fiber Feed Additives
- Portable Incubators
- Amitriptyline Hydrochloride
- And 31 more healthcare products.
To order your complimentary copy of the Drug and Device Customs Ruling Summary today, fill out the form below or contact your account representative at +1-800-771-9202.